Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Gene Signal International SA - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Gene Signal International SA - Product Pipeline Review - 2014', provides an overview of the Gene Signal International SA's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Gene Signal International SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Gene Signal International SA including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Gene Signal International SA's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Gene Signal International SA's pipeline products Reasons to buy - Evaluate Gene Signal International SA's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Gene Signal International SA in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Gene Signal International SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Gene Signal International SA and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Gene Signal International SA - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Gene Signal International SA and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Gene Signal International SA Snapshot 5 Gene Signal International SA Overview 5 Key Information 5 Key Facts 5 Gene Signal International SA - Research and Development Overview 6 Key Therapeutic Areas 6 Gene Signal International SA - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Gene Signal International SA - Pipeline Products Glance 11 Gene Signal International SA - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Gene Signal International SA - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Gene Signal International SA - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Discovery Products/Combination Treatment Modalities 15 Gene Signal International SA - Drug Profiles 16 aganirsen 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 GS-156 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 GS-168 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 GS-497-c 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 GS-156 MAb 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Gene Signal International SA - Pipeline Analysis 22 Gene Signal International SA - Pipeline Products by Target 22 Gene Signal International SA - Pipeline Products by Route of Administration 23 Gene Signal International SA - Pipeline Products by Molecule Type 24 Gene Signal International SA - Pipeline Products by Mechanism of Action 25 Gene Signal International SA - Recent Pipeline Updates 26 Gene Signal International SA - Dormant Projects 27 Gene Signal International SA - Locations And Subsidiaries 28 Head Office 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30
List of Tables Gene Signal International SA, Key Information 5 Gene Signal International SA, Key Facts 5 Gene Signal International SA - Pipeline by Indication, 2014 8 Gene Signal International SA - Pipeline by Stage of Development, 2014 9 Gene Signal International SA - Monotherapy Products in Pipeline, 2014 10 Gene Signal International SA - Phase III, 2014 11 Gene Signal International SA - Phase II, 2014 12 Gene Signal International SA - Phase I, 2014 13 Gene Signal International SA - Preclinical, 2014 14 Gene Signal International SA - Discovery, 2014 15 Gene Signal International SA - Pipeline by Target, 2014 22 Gene Signal International SA - Pipeline by Route of Administration, 2014 23 Gene Signal International SA - Pipeline by Molecule Type, 2014 24 Gene Signal International SA - Pipeline Products by Mechanism of Action, 2014 25 Gene Signal International SA - Recent Pipeline Updates, 2014 26 Gene Signal International SA - Dormant Developmental Projects,2014 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.